Your browser doesn't support javascript.
loading
Durability of mRNA-1273 vaccine-induced antibodies against SARS-CoV-2 variants.
Pegu, Amarendra; O'Connell, Sarah E; Schmidt, Stephen D; O'Dell, Sijy; Talana, Chloe A; Lai, Lilin; Albert, Jim; Anderson, Evan; Bennett, Hamilton; Corbett, Kizzmekia S; Flach, Britta; Jackson, Lisa; Leav, Brett; Ledgerwood, Julie E; Luke, Catherine J; Makowski, Mat; Nason, Martha C; Roberts, Paul C; Roederer, Mario; Rebolledo, Paulina A; Rostad, Christina A; Rouphael, Nadine G; Shi, Wei; Wang, Lingshu; Widge, Alicia T; Yang, Eun Sung; Beigel, John H; Graham, Barney S; Mascola, John R; Suthar, Mehul S; McDermott, Adrian B; Doria-Rose, Nicole A; Arega, Jae; Beigel, John H; Buchanan, Wendy; Elsafy, Mohammed; Hoang, Binh; Lampley, Rebecca; Kolhekar, Aparna; Koo, Hyung; Luke, Catherine; Makhene, Mamodikoe; Nayak, Seema; Pikaart-Tautges, Rhonda; Roberts, Paul C; Russell, Janie; Sindall, Elisa; Albert, Jim; Kunwar, Pratap; Makowski, Mat.
Affiliation
  • Pegu A; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
  • O'Connell SE; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
  • Schmidt SD; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
  • O'Dell S; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
  • Talana CA; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
  • Lai L; Department of Pediatrics, Division of Infectious Disease, Emory Vaccine Center, Yerkes National Primate Research Center, Emory University School of Medicine, Atlanta, GA 30322, USA.
  • Albert J; Emmes Company, Rockville, MD 20850, USA.
  • Anderson E; Department of Pediatrics, Division of Infectious Disease, Emory Vaccine Center, Yerkes National Primate Research Center, Emory University School of Medicine, Atlanta, GA 30322, USA.
  • Bennett H; Moderna, Inc., Cambridge, MA 02139, USA.
  • Corbett KS; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
  • Flach B; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
  • Jackson L; Kaiser Permanente Washington Health Research Institute, Seattle, WA 98101, USA.
  • Leav B; Moderna, Inc., Cambridge, MA 02139, USA.
  • Ledgerwood JE; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
  • Luke CJ; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
  • Makowski M; Emmes Company, Rockville, MD 20850, USA.
  • Nason MC; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
  • Roberts PC; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
  • Roederer M; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
  • Rebolledo PA; Hope Clinic, Department of Medicine, Emory University School of Medicine, Decatur, GA 30030, USA.
  • Rostad CA; Department of Pediatrics, Division of Infectious Disease, Emory Vaccine Center, Yerkes National Primate Research Center, Emory University School of Medicine, Atlanta, GA 30322, USA.
  • Rouphael NG; Hope Clinic, Department of Medicine, Emory University School of Medicine, Decatur, GA 30030, USA.
  • Shi W; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
  • Wang L; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
  • Widge AT; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
  • Yang ES; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
  • Beigel JH; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
  • Graham BS; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
  • Mascola JR; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
  • Suthar MS; Department of Pediatrics, Division of Infectious Disease, Emory Vaccine Center, Yerkes National Primate Research Center, Emory University School of Medicine, Atlanta, GA 30322, USA.
  • McDermott AB; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
  • Doria-Rose NA; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Science ; 373(6561): 1372-1377, 2021 Sep 17.
Article in En | MEDLINE | ID: mdl-34385356
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antibodies, Neutralizing / COVID-19 Vaccines / SARS-CoV-2 / Antibodies, Viral Limits: Adolescent / Adult / Aged / Humans / Middle aged Language: En Journal: Science Year: 2021 Document type: Article Affiliation country: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antibodies, Neutralizing / COVID-19 Vaccines / SARS-CoV-2 / Antibodies, Viral Limits: Adolescent / Adult / Aged / Humans / Middle aged Language: En Journal: Science Year: 2021 Document type: Article Affiliation country: United States